Experts and Regulation

-

 It’s difficult to deliver cohesive healthcare with discongruence in the regulation and scope of medicine. We cannot anticipate, plan for, solve for, intervene with or efficiently standardize healthcare without some evenness to healthcare. 


For all the global health coordination, and all the international research collaboration, there is no movement toward scope of practice, labor regulation, prescribing regulation or biotechnological responsibility standardization. 


We should encourage measured, quantitative progress toward accountability in medicine regulation, and we should require quality to the process. 


  • *What are the medical professions, credentials, approved education and scope of practice in healthcare, per country? What are the community healthcare worker (CHW) roles if allowed, per country? 

  • *Which procedures are allowed for each healthcare profession? 

  • *What are the differences in approvals and guidelines for medicine safety, and for who can prescribe what? 

  • *What are the rules for over the counter medication, by country? 

  • *What are the timelines, progress indicators and metrics for the basic comparison listing of healthcare professional regulations? 

  • *What are the timelines, progress indicators and metrics toward goals of listing and accounting for medicine regulation? 

  • *What is the evidence for current scope of practice for all healthcare professions? 

  • *What is the estimated cost of time, money and other resources when global coordination is hindered by inconsistent medicine and labor rules? 

  • *What are the audit and validation tools for healthcare education, by credential? 

  • *What is the planned data aggregation and research to better shape professional regulation in healthcare?  

  • *What are the differences in health outcomes and in patient safety outcomes with various over the counter rules? 

  • *What is the strategic plan for health and safety outcome evaluations, by country, by prescribing rules? 



For global health to boost credibility, some understanding and accounting for medicine’s professional allowance is necessary. The current lack of listing or comparison of professional scope of practice, and of prescribing regulation, suggests that the industry is even more varied than anticipated. Global health must account for international differences in medical scope of practice, and should do so with quality to the process.


Comments

Post a Comment

Popular posts from this blog

Personal Protective Equipment

-
Personal Protective Equipment (PPE) is a routine in healthcare. However, the norms and standards vary from organization to organization, fracturing the opportunities that accompany routine. Supply type, brand, processes, costs, scientific review with product approvals, labor regulatory oversight, HCW application and attention to infection prevention with PPE use all vary widely across institutions, states and countries. This variance is unfortunate, given that the pathogen does not change character simply because it is in a different building or geographical territory. We have an opportunity to improve the short term and long term approach to PPE worldwide. We can best structure this opportunity by observing quantity and quality.  The short term quantity and quality of PPE should focus on guidelines, norms and immediate need. The short term should be directed with global effort.   The long term quantity and quality of PPE should observe innovative and transformative approaches...
Read more

Vaccination

-
Vaccination is our best bet for relief from the pandemic crisis.  Quality - The quality of vaccination could be strengthened with international coordination of real time analysis: percentage of vaccinated who test positive, percentage of vaccinated positives with symptoms, comparison by travel and border, comparison by product. -  T he quality of vaccination could be strengthened by global consensus to definition of breakthrough. -  T he quality of vaccination could be strengthened by additional dosing and timing of dosing data.  - T he quality of vaccination could measure success by primary variant in circulation.  - The quality of vaccination could be strengthened by ongoing open data with SARS research. Quantity  - The quantity of people served by public health could be strengthened with a real time map, a basic visual, for philanthropic and governmental reference. Where is the product, how much is still needed, and what is the trajectory for the country...
Read more

The Right Direction

-
  Roads Transportation barriers, and alternatives to transportation in healthcare, remain opaque in delivery focus. Given the sophistication in global citizenry and global policy, as well as the sophistication of climate science evolution, oversight for transportation in healthcare can be improved. Healthcare transportation oversight should focus on improvement to both quantity and quality.   Quantity *Collaborate and clarify the impact of transportation on healthcare. How much healthcare is missed due to lack of transportation? Estimates of deferred visits due to transportation barriers are available as piecemeal [1,2]. Be specific for populations, too. Global health data may isolate specific case studies. United States or other high-income countries may research healthcare transportation as a social determinant of care [3], without specifics on cost, cost savings, or the barrier’s impact on healthcare. It would be best to have ongoing, reliable data on health burden and impa...
Read more